Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments.
Mahmoud S. Alghamri,Brandon L. McClellan,Margaret S. Hartlage,Santiago Haase,Syed M Faisal,Rohit Thalla,Ali Dabaja,Kaushik Banerjee,Stephen Carney,Anzar A. Mujeeb,Michael R. Olin,James J. Moon,Anna Schwendeman,Pedro R. Lowenstein,Maria G. Castro +14 more
Reads0
Chats0
TLDR
Glioblastomas are one of the most lethal types of cancers accounting for ~80% of all central nervous system (CNS) primary malignancies [1, as discussed by the authors.Abstract:
Gliomas are one of the most lethal types of cancers accounting for ~80% of all central nervous system (CNS) primary malignancies [1; 2]. Amongst gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies uncovered the genetic signatures and methylation status of gliomas and correlate these with clinical prognosis [2]. The most relevant molecular characteristics for the new glioma classification are IDH mutation, chromosome 1p/19q deletion, histone mutations, and other genetic parameters such as ATRX loss, TP53, and TERT mutations, as well as DNA methylation levels. Similar to other solid tumors, glioma progression is impacted by the complex interactions between the tumor cells and immune cells within the tumor microenvironment. The immune system’s response to cancer can impact the glioma’s survival, proliferation, and invasiveness. Salient characteristics of gliomas include enhanced vascularization, stimulation of a hypoxic tumor microenvironment, increased oxidative stress, and an immune suppressive milieu. These processes promote the neuro-inflammatory tumor microenvironment which can lead to the loss of blood-brain barrier (BBB) integrity. The consequences of a compromised BBB are deleteriously exposing the brain to potentially harmful concentrations of substances from the peripheral circulation, adversely affecting neuronal signaling, and abnormal immune cell infiltration; all of which can lead to disruption of brain homeostasis. In this review, we first describe the unique features of inflammation in CNS tumors. We then discuss the mechanisms of tumor-initiating neuro-inflammatory microenvironment and its impact on tumor invasion and progression. Finally, we also discuss potential pharmacological interventions that can be used to target neuro-inflammation in gliomas.read more
Citations
More filters
Journal ArticleDOI
RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS
Reshma Raghava Kurup,Eimile Oakes,Aidan C. Manning,Priyanka Mukherjee,Pranathi Vadlamani,Heather A. Hundley +5 more
TL;DR: In this article , a global view of ADAR3-bound RNAs in glioblastoma cells and identifies both a role for ADAR-3 in repressing ADAR1-mediated editing and an RNA-binding dependent function of adar3 in regulating MAVS expression.
Journal ArticleDOI
Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches.
TL;DR: In this article, a review of recent advances in imaging methods that have helped to improve the specificity of primary tumor diagnosis versus evaluation of inflamed and necrotic brain lesions is presented.
Journal ArticleDOI
Dopamine, Immunity, and Disease
Breana Channer,Stephanie M. Matt,E. A. Nickoloff-Bybel,Vassiliki Pappa,Yash Agarwal,Jason R Wickman,Peter J. Gaskill +6 more
TL;DR: In this article , a review comprehensively assesses the current knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopamine regulation of immunity.
Journal ArticleDOI
Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen,Marwa M. Nagib,Nelufar Yasmen,Madison N. Sluter,Taylor L Littlejohn,Ying Yu,Jianxiong Jiang +6 more
Journal ArticleDOI
Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus
TL;DR: The risk of malignant brain tumors associated with metformin use has rarely been investigated in humans as discussed by the authors, and the authors in this retrospective cohort study investigated such an association in humans.
References
More filters
Journal ArticleDOI
Dendritic cells: a link between innate and adaptive immunity.
TL;DR: Understanding of DC biology is still in its infancy, but it is now in a position to use DC-based immunotherapy protocols to treat cancer and infectious diseases.
Journal ArticleDOI
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.
Einar O. Vik-Mo,Marta Nyakas,Birthe Viftrup Mikkelsen,Birthe Viftrup Mikkelsen,Morten C. Moe,Paulina Due-Tönnesen,Else Marit Inderberg Suso,Stein Sæbøe-Larssen,Cecilie Sandberg,Cecilie Sandberg,Jan E. Brinchmann,Eirik Helseth,Anne Marie Rasmussen,Knut Lote,Steinar Aamdal,Gustav Gaudernack,Gunnar Kvalheim,Iver A. Langmoen +17 more
TL;DR: These findings suggest that vaccination against glioblastoma stem cells is safe, well-tolerated, and may prolong progression-free survival.
Journal ArticleDOI
Gliomas and the vascular fragility of the blood brain barrier
Luiz Gustavo Dubois,Loraine Campanati,Cassia Righy,Isabella D’Andrea-Meira,Tania Cristina Leite de Sampaio e Spohr,Isabel Porto-Carreiro,Cláudia Pereira,Joana Balça-Silva,Suzana Assad Kahn,Marcos F. DosSantos,Marcela de Almeida Rabello Oliveira,Adriana Ximenes-da-Silva,Maria do Carmo Lopes,Eduardo C. Faveret,Emerson Leandro Gasparetto,Vivaldo Moura-Neto +15 more
TL;DR: Astrocytes, members of the glial family, interact through the exchange of soluble factors or by directly contacting neurons and other brain cells, such as microglia and endothelial cells, and act as additional elements of the Blood Brain Barrier (BBB).
Journal ArticleDOI
The disturbed blood–brain barrier in human glioblastoma
TL;DR: Altered alterations of the blood-brain barrier (BBB) in gliomas are described to lead to a breakdown of the BBB characterized by disturbed tight junctions, and thus to the development of vasogenic edema.
Journal ArticleDOI
Neuroinflammation: Microglia and T Cells Get Ready to Tango.
TL;DR: Recent findings that unite the paradigms of microglial functioning, antigen presentation, and CNS-directed T cell activation, focusing on common neurodegenerative diseases are reviewed, providing an important update on CNS adaptive immunity, novel targets, and a concept of the microglia T-cell equilibrium.